No Data
ADRs End Lower; Kazia Therapeutics Ltd. Declines 18%
Kazia Therapeutics KZIA +248% Phase 2/3 Data; Longeveron LGVN +59% RMAT Designation
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Dow Jumps 100 Points; Producer Inflation Surpasses Expectations For June